UTRGV International Conference on Health Disparities: Treatment and Recovery from Opioid and Alcohol Use Disorders and Related Comorbidities (ICHD-Recover)

UTRGV 健康差异国际会议:阿片类药物和酒精使用障碍及相关合并症的治疗和康复 (ICHD-Recover)

基本信息

  • 批准号:
    10469128
  • 负责人:
  • 金额:
    $ 3.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT The University of Texas Rio Grande Valley (UTRGV), the second largest Hispanic-serving institution in the nation, founded the School of Medicine (SOM) in 2015 to address the health needs of the underrepresented minority (URM) populations of south Texas on the US-Mexico border. In 2017, as part of its mission, the SOM began hosting an annual research conference on health disparities. The conference was the first of its kind in the Rio Grande Valley (RGV). To date, more than half the participants have been URMs and women. Each year since 2017 UTRGV has held a health disparities research conference that has attracted more than 300 attendees each year. With expected participation from both US and Mexico border institutions, the UTRGV-SOM will host the 5th and 6th conferences on September 9-10, 2022, and September 8-9, 2023. The title will be “International Conference on Health Disparities: Treatment and Recovery from Opioid and Alcohol Use Disorders and Related Comorbidities (ICHD-Recover).” Opioid and alcohol use disorders are significant national public health problems and are particularly severe among URM populations. The ICHD-Recover has the following Specific Aims: 1) To accelerate collaborations among researchers at the national level and across the U.S.-Mexico border, 2) To facilitate engagement and collaboration with community stakeholders in research and implementation of culturally relevant interventions, thus obtaining community support for research on substance use disorders, 3) To stimulate new lines of research addressing URM health with a focus on opioid and alcohol use disorders and related comorbidities, 4) To motivate trainees from URM populations to engage in substance abuse research, and 5) To disseminate research findings from the Rio Grande Valley (RGV) to researchers and health policy makers in other border regions and states and the nation. The proposed conferences will include nationally known speakers, plenary sessions, abstracts, and posters presented by students, researchers, fellows, faculty, and professionals from the U.S. and neighboring Mexican border institutions. Seventy five percent of our speakers are from URM. Funds will be used to 1) invite leading researchers, health disparity experts and young scientists, from the U.S. border regions and Mexico, and 2) implement the proposed scientific agenda over two days, thus showcasing community-engaged research in which researchers and practitioners address opioid and alcohol use disorder health disparities in URM populations. The ICHD-Recover closely aligns with the NIH mission, which is to support global opioid and alcohol use disorders and health disparities research to advance scientific knowledge and aid all those affected to recover from the consequences of opioid and alcohol misuse. The ICHD-Recover conferences will, 1) emphasize how the medical research community can most effectively interact with community stakeholders, considering the social determinants of health to inform the design and implementation of community intervention programs, and 2) address health disparities in persons suffering from the consequences of opioid and alcohol misuse and associated comorbidities in URM populations.
摘要 德克萨斯大学格兰德河谷(UTRGV)是世界上第二大拉美裔服务机构 国家,于2015年成立了医学院(SOM),以满足代表不足的人的健康需求 德克萨斯州南部美墨边境的少数民族(URM)人口。2017年,作为其使命的一部分,高级官员会议 开始主持关于健康差距的年度研究会议。这是#年的第一次此类会议。 格兰德河谷(RGV)。到目前为止,超过一半的参与者是城市管理人员和妇女。每年 自2017年以来,UTRGV举办了一次健康差距研究会议,吸引了300多人参加 每年。预计将有美国和墨西哥边境机构参与,UTRGV-SOM将主办 2022年9月9日至10日和2023年9月8日至9日举行的第五次和第六次会议。书名将是《国际》 健康差距会议:阿片类药物和酒精使用障碍及相关疾病的治疗和恢复 合并症(ICHD-RECOVER)。阿片类药物和酒精使用障碍是严重的国家公共卫生问题 在URM人群中尤为严重。排雷中心--恢复工作有以下具体目标:1) 加快国家层面和美墨边境研究人员之间的合作,2) 促进社区利益攸关方在研究和实施方面的参与和协作 与文化相关的干预措施,从而获得社区对物质使用障碍研究的支持,3) 鼓励开展新的研究,重点关注阿片类药物和酒精使用障碍,解决URM健康问题 相关的合并症,4)激励来自URM人群的受训人员从事药物滥用研究, 5)将格兰德河谷(RGV)的研究成果传播给研究人员和卫生政策 其他边境地区、州和国家的制造商。拟议的会议将包括全国范围内的 著名的演讲者、全体会议、摘要和海报由学生、研究人员、研究员、教职员工、 以及来自美国和邻近的墨西哥边境机构的专业人士。我们75%的人 演讲者来自URM。资金将用于1)邀请顶尖研究人员、健康差距专家和年轻人 来自美国边境地区和墨西哥的科学家,以及2)在两年多的时间里实施拟议的科学议程 几天,从而展示了社区参与的研究,在这些研究中,研究人员和从业者解决了阿片类药物和 酒精使用障碍在URM人群中的健康差异。ICHD-RECOVER与美国国立卫生研究院密切相关 使命是支持全球阿片类药物和酒精使用障碍和健康差距研究,以推动 科学知识和帮助所有受影响的人从阿片类药物和酒精滥用的后果中恢复过来。 ICHD-RECOVER会议将:1)强调医学研究界如何最有效地 与社区利益相关者互动,考虑健康的社会决定因素,为设计和 实施社区干预方案,以及2)解决患有以下疾病的人的健康差距 阿片类药物和酒精滥用以及相关的URM人群共病的后果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IHSAN M SALLOUM其他文献

IHSAN M SALLOUM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IHSAN M SALLOUM', 18)}}的其他基金

UTRGV International Conference on Health Disparities: Treatment and Recovery from Opioid and Alcohol Use Disorders and Related Comorbidities (ICHD-Recover)
UTRGV 健康差异国际会议:阿片类药物和酒精使用障碍及相关合并症的治疗和康复 (ICHD-Recover)
  • 批准号:
    10649618
  • 财政年份:
    2022
  • 资助金额:
    $ 3.1万
  • 项目类别:
Stem Cell Therapy, Inflammation and Treatement Response in Alcholoism-Depression Comobidity
酒精中毒-抑郁症合并症的干细胞治疗、炎症和治疗反应
  • 批准号:
    10252067
  • 财政年份:
    2020
  • 资助金额:
    $ 3.1万
  • 项目类别:
Stem Cell Therapy, Inflammation and Treatement Response in Alcholoism-Depression Comobidity
酒精中毒-抑郁症合并症的干细胞治疗、炎症和治疗反应
  • 批准号:
    10187777
  • 财政年份:
    2020
  • 资助金额:
    $ 3.1万
  • 项目类别:
Optimizing Pharmacotherapy for Bipolar Alcoholics
优化双相酗酒者的药物治疗
  • 批准号:
    7029989
  • 财政年份:
    2006
  • 资助金额:
    $ 3.1万
  • 项目类别:
Optimizing Pharmacotherapy for Bipolar Alcoholics
优化双相酗酒者的药物治疗
  • 批准号:
    7174267
  • 财政年份:
    2006
  • 资助金额:
    $ 3.1万
  • 项目类别:
Optimizing Pharmacotherapy for Bipolar Alcoholics
优化双相酗酒者的药物治疗
  • 批准号:
    7368095
  • 财政年份:
    2006
  • 资助金额:
    $ 3.1万
  • 项目类别:
Optimizing Pharmacotherapy for Bipolar Alcoholics
优化双相酗酒者的药物治疗
  • 批准号:
    7432310
  • 财政年份:
    2006
  • 资助金额:
    $ 3.1万
  • 项目类别:
Optimizing Pharmacotherapy for Bipolar Alcoholics
优化双相酗酒者的药物治疗
  • 批准号:
    7576202
  • 财政年份:
    2006
  • 资助金额:
    $ 3.1万
  • 项目类别:
Optimizing Pharmacotherapy for Bipolar Alcoholics
优化双相酗酒者的药物治疗
  • 批准号:
    7778938
  • 财政年份:
    2006
  • 资助金额:
    $ 3.1万
  • 项目类别:
Valproate Efficacy in Cocaine-Bipolar Comorbidity
丙戊酸治疗可卡因双相情感障碍的疗效
  • 批准号:
    7640768
  • 财政年份:
    2005
  • 资助金额:
    $ 3.1万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了